Our Clinical Pharmacy and Outcomes Sciences faculty engaged in pharmacoeconomics measure outcomes via cost-minimization analysis (CMA), cost-benefit analysis (CBA), cost-effectiveness analysis (CEA) and cost-utility analysis (CUA).
Each type of outcome management is associated with a different type of pharmacoeconomic analysis. Decision makers can use these methods to evaluate and compare the total costs of treatment options and the outcomes associated with these options.
Reference:
Wilson JP, Rascati KL. Pharmacoeconomics. In: Malone PM, Kier KL, Stanovich JE, Malone
MJ. eds. Drug Information: A Guide for Pharmacists 5e. New York, NY: McGraw-Hill;
2013.